Cadila Pharma launched ulcer drug
The Rs. 500-crore Cadila Pharmaceuticals Ltd. (CPL) has received the Drug Controller-General of India (DCGI) permission to launch reabeprazole sodium in the country. The drug, an anti-ulcerant for
The Rs. 500-crore Cadila Pharmaceuticals Ltd. (CPL) has received the Drug Controller-General of India (DCGI) permission to launch reabeprazole sodium in the country. The drug, an anti-ulcerant for